LCT Of New Zealand Buys Stake In U.S. Pig Cell Owner For Wound Healing
This article was originally published in PharmAsia News
Executive Summary
New Zealand's Living Cell Technologies has obtained a 10 percent stake in CytoSolv of the United States, paying for the shares with pig cells